These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Metabolism of a beta blocking drug, oxprenolol. Garteiz DA J Pharmacol Exp Ther; 1971 Nov; 179(2):354-8. PubMed ID: 4399963 [No Abstract] [Full Text] [Related]
6. Bunolol metabolism by cell-free preparations of human liver: biosynthesis of dihydrobunolol. Leinweber FJ; Greenough RC; Schwender CF; Kaplan HR; Di Carlo FJ Xenobiotica; 1972 Mar; 2(2):191-202. PubMed ID: 4560367 [No Abstract] [Full Text] [Related]
7. Metabolic studies on oxprenolol in animals and man by means of radio-tracer techniques and GLC-analysis. Riess W; Rajagopalan TG; Imhof P; Schmid K; Keberle H Postgrad Med J; 1970 Nov; ():Suppl:32-9. PubMed ID: 4395455 [No Abstract] [Full Text] [Related]
8. The pharmacokinetics and metabolism of Kö592 in man, dog and rat. Arndts D; Pollmann W Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(4):349-62. PubMed ID: 4145200 [No Abstract] [Full Text] [Related]
9. Additional routes in the metabolism of nicotine to 3-pyridylacetate. The metabolism of dihydrometanicotine. Meacham RH; Bowman ER; McKennis H J Biol Chem; 1972 Feb; 247(3):902-8. PubMed ID: 5058231 [No Abstract] [Full Text] [Related]
10. The metabolism and distribution of the selective adrenergic beta blocking agent, practolol. Scales B; Cosgrove MB J Pharmacol Exp Ther; 1970 Nov; 175(2):338-47. PubMed ID: 4394800 [No Abstract] [Full Text] [Related]
11. Absorption of alprenolol in man from tablets with different rates of release. Johansson R; Regårdh CG; Sjögren J Acta Pharm Suec; 1971 Mar; 8(1):59-70. PubMed ID: 4396952 [No Abstract] [Full Text] [Related]
13. l-bunolol metabolites in human urine. Leinweber FJ; Szpiech JM; Di Carlo FJ Pharmacology; 1978; 16(2):70-7. PubMed ID: 339235 [TBL] [Abstract][Full Text] [Related]
14. Effects of alprenolol, bunolol and propranolol on pulmonary resistance in the anaesthetized dog. Giles RE; Finkel MP Eur J Pharmacol; 1971 Oct; 16(2):155-63. PubMed ID: 4405779 [No Abstract] [Full Text] [Related]
15. Distribution kinetics and intestinal absorption of practolol in the rat. Barber HE; Bourne GR Br J Pharmacol; 1971 Mar; 41(3):513-20. PubMed ID: 4396971 [TBL] [Abstract][Full Text] [Related]
16. Bunolol metabolism by dogs: identification of basic metabolites and their conjugates. Leinweber FJ; Greenough RC; Di Carlo FJ J Pharm Sci; 1977 Nov; 66(11):1570-5. PubMed ID: 335043 [TBL] [Abstract][Full Text] [Related]
17. Metabolic studies of Salbutanol-3H: a new bronchodilator, in rat, rabbit, dog and man. Martin LE; Hobson JC; Page JA; Harrison C Eur J Pharmacol; 1971 Apr; 14(2):183-99. PubMed ID: 5164253 [No Abstract] [Full Text] [Related]
18. Tissue distribution in rats of 1-(4'-nitrophenyl)-2-isopropylaminoethanol hydrochloride (INPEA) a highly specific beta-adrenergic blocking agent. Almirante L; Murmann W; Rugarli P; Fazi L Farmaco Sci; 1966 Sep; 21(9):637-44. PubMed ID: 5971374 [No Abstract] [Full Text] [Related]
19. Derivatives of 3,4-dihydro-1(2H)-naphthalenone as beta-adrenergic blocking agents. I. Bunolol and related analogs. Schwender CF; Farber S; Blaum C; Shavel J J Med Chem; 1970 Jul; 13(4):684-8. PubMed ID: 4393796 [No Abstract] [Full Text] [Related]
20. A study in vitro of new short-acting, non-depolarizing neuromuscular blocking agents. Kitz RJ; Karis JH; Ginsburg S Biochem Pharmacol; 1969 Apr; 18(4):871-81. PubMed ID: 5788524 [No Abstract] [Full Text] [Related] [Next] [New Search]